INNOVANCE VWF Ac assay is under review by FDA as a de novo classification request. An approval is pending and the product is not yet commercially available in the United States.
Bodo I, et al. Platelet dependent von Willebrand factor activity. Nomenclature and methodology:communication from the SSC of the ISTH. J Thromb Haemost 2015;13:1345–50.
James PD, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. 2021 Jan 12 [published online].
INNOVANCE, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. Sysmex is
a trademark of the Sysmex Corporation. All other trademarks and brands are the property of their respective owners.
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.